
In this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ESMO 2026 Congress.
The move to have patients shoulder greater share of their cost of care is particularly challenging in cancer care, according to Jennifer Malin, MD, medical director for oncology at Anthem.
The move to have patients shoulder greater share of their cost of care is particularly challenging in cancer care, according to Jennifer Malin, MD, medical director for oncology at Anthem.
Coming up with the several thousand dollars that is needed can be overwhelming for patients, and if they are on the bronze plan on the health insurance exchange, then they might need to come up with something like $6000, she explained.
"It's overwhelming when you have a major illnes that's going to be so costly," Dr Malin said.






